Core Viewpoint - The company Shijiazhuang Pharmaceutical Group has received approval from the National Medical Products Administration of China for its Vitamin A Palmitate to be registered as an active pharmaceutical ingredient for use in marketed formulations [1] Group 1 - The approved Vitamin A Palmitate is primarily used in fat-soluble vitamin injection solutions to supplement vitamins [1]

Core Viewpoint - The company Shijiazhuang Pharmaceutical Group has received approval from the National Medical Products Administration of China for its Vitamin A Palmitate to be used as an active pharmaceutical ingredient in marketed formulations [1] Group 1 - The approved Vitamin A Palmitate is primarily used in fat-soluble vitamin injection solutions to supplement vitamins [1]

格隆汇11月27日丨石四药集团(02005.HK)公告，集团的维生素A棕榈酸酯已获中国国家药品监督管理局 批准登记成为在上市制剂使用的原料药。维生素A棕榈酸酯主要用于脂溶性维生素注射液，补充维生 素。 ...

石四药集团(02005)公布，该集团的维生素A棕榈酸酯已获中国国家药品监督管理局批准登记成为在上市 制剂使用的原料药。维生素A棕榈酸酯主要用于脂溶性维生素注射液，补充维生素。 ...